Primary extrauterine endometrial stromal cell sarcoma: A case and review

Alla Zemlyak, Sonya Hwang, Eva Chalas, Colette R.J. Pameijer

Research output: Contribution to journalShort survey

12 Citations (Scopus)

Abstract

Background: Extrauterine endometrial stromal sarcoma (ESS) is a rare neoplasm. Little is known about its pathophysiology or best treatment approach. Case: We are describing a case of extrauterine ESS in a 70-year-old woman on hormone replacement therapy and with a history of endometriosis. We also present a brief review of the literature on ESS and its relationship to endometriosis and hormonal therapy. Conclusions: Complete resection should remain the treatment of choice for ESS. Unresectable or metastatic low-grade ESS may respond well to progestin therapy, but outcomes of high-grade ESS tend to be poor.

Original languageEnglish (US)
Pages (from-to)104-106
Number of pages3
JournalJournal of Gastrointestinal Cancer
Volume39
Issue number1-4
DOIs
StatePublished - Mar 1 2008

Fingerprint

Endometrial Stromal Sarcoma
Stromal Cells
Endometriosis
Endometrial Stromal Tumors
Hormone Replacement Therapy
Progestins
Therapeutics
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Gastroenterology

Cite this

Zemlyak, Alla ; Hwang, Sonya ; Chalas, Eva ; Pameijer, Colette R.J. / Primary extrauterine endometrial stromal cell sarcoma : A case and review. In: Journal of Gastrointestinal Cancer. 2008 ; Vol. 39, No. 1-4. pp. 104-106.
@article{240a150dbc2b4ba39a4acc83994a42d3,
title = "Primary extrauterine endometrial stromal cell sarcoma: A case and review",
abstract = "Background: Extrauterine endometrial stromal sarcoma (ESS) is a rare neoplasm. Little is known about its pathophysiology or best treatment approach. Case: We are describing a case of extrauterine ESS in a 70-year-old woman on hormone replacement therapy and with a history of endometriosis. We also present a brief review of the literature on ESS and its relationship to endometriosis and hormonal therapy. Conclusions: Complete resection should remain the treatment of choice for ESS. Unresectable or metastatic low-grade ESS may respond well to progestin therapy, but outcomes of high-grade ESS tend to be poor.",
author = "Alla Zemlyak and Sonya Hwang and Eva Chalas and Pameijer, {Colette R.J.}",
year = "2008",
month = "3",
day = "1",
doi = "10.1007/s12029-009-9064-0",
language = "English (US)",
volume = "39",
pages = "104--106",
journal = "Journal of Gastrointestinal Cancer",
issn = "1941-6628",
publisher = "Humana Press",
number = "1-4",

}

Primary extrauterine endometrial stromal cell sarcoma : A case and review. / Zemlyak, Alla; Hwang, Sonya; Chalas, Eva; Pameijer, Colette R.J.

In: Journal of Gastrointestinal Cancer, Vol. 39, No. 1-4, 01.03.2008, p. 104-106.

Research output: Contribution to journalShort survey

TY - JOUR

T1 - Primary extrauterine endometrial stromal cell sarcoma

T2 - A case and review

AU - Zemlyak, Alla

AU - Hwang, Sonya

AU - Chalas, Eva

AU - Pameijer, Colette R.J.

PY - 2008/3/1

Y1 - 2008/3/1

N2 - Background: Extrauterine endometrial stromal sarcoma (ESS) is a rare neoplasm. Little is known about its pathophysiology or best treatment approach. Case: We are describing a case of extrauterine ESS in a 70-year-old woman on hormone replacement therapy and with a history of endometriosis. We also present a brief review of the literature on ESS and its relationship to endometriosis and hormonal therapy. Conclusions: Complete resection should remain the treatment of choice for ESS. Unresectable or metastatic low-grade ESS may respond well to progestin therapy, but outcomes of high-grade ESS tend to be poor.

AB - Background: Extrauterine endometrial stromal sarcoma (ESS) is a rare neoplasm. Little is known about its pathophysiology or best treatment approach. Case: We are describing a case of extrauterine ESS in a 70-year-old woman on hormone replacement therapy and with a history of endometriosis. We also present a brief review of the literature on ESS and its relationship to endometriosis and hormonal therapy. Conclusions: Complete resection should remain the treatment of choice for ESS. Unresectable or metastatic low-grade ESS may respond well to progestin therapy, but outcomes of high-grade ESS tend to be poor.

UR - http://www.scopus.com/inward/record.url?scp=69849110036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69849110036&partnerID=8YFLogxK

U2 - 10.1007/s12029-009-9064-0

DO - 10.1007/s12029-009-9064-0

M3 - Short survey

C2 - 19333789

AN - SCOPUS:69849110036

VL - 39

SP - 104

EP - 106

JO - Journal of Gastrointestinal Cancer

JF - Journal of Gastrointestinal Cancer

SN - 1941-6628

IS - 1-4

ER -